Grassi Silvarosa, Frondaroli Adele, Pettorossi Vito Enrico
Department of Internal Medicine, Section of Human Physiology, University of Perugia, Perugia I-06100, Italy.
J Physiol. 2002 Sep 15;543(Pt 3):795-806. doi: 10.1113/jphysiol.2002.023424.
In the medial vestibular nuclei (MVN) of rat brainstem slices, the role of group II and III metabotropic glutamate receptors (mGluRs) and of the subtypes of group I mGluRs: mGluR1, mGluR5, was investigated in basal synaptic transmission and in the induction and maintenance of long-term potentiation (LTP). We used selective antagonists and agonists for mGluRs and we analysed the field potentials evoked by vestibular afferent stimulation before and after high-frequency stimulation (HFS) to induce LTP. The group II and III mGluR antagonist, (R,S)-alpha-2-methyl-4sulphonophenylglycine (MSPG), induced LTP per se and caused a reduction of the paired-pulse facilitation (PPF) ratio indicating an enhancement of glutamate release. This suggests that group II and III mGluRs are activated under basal conditions to limit glutamate release. Both the group II and III mGluR selective antagonists, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoate (LY341495) and (R,S)-alpha-methylserine-O-phosphate (MSOP), induced LTP, and the selective agonists, (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (APDC) and L(+)-2-amino-4-phosphonobutyric acid (L-AP4) depressed the field potentials and prevented HFS-LTP, with a prevailing contribution of group II mGluRs over that of group III mGluRs. The mGluR1 antagonist, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt) prevented the full development and maintenance of HFS-LTP. By contrast, the mGluR5 antagonist, 2-methyl-6-phenylethynylpyridine (MPEP) induced LTP per se, which was impeded by CPCCOEt, and it had no effect on LTP once induced by HFS. The PPF analysis showed an enhancement of glutamate release during MPEP potentiation. The group I mGluR agonist, (R,S)-3,5-dihydroxyphenylglycine (DHPG) induced LTP per se, which was blocked by CPCCOEt. By contrast the mGluR5 agonist, (R,S)-2-chloro-5-hydroxypheylglycine (CHPG) prevented LTP elicited by HFS and DHPG as well. In conclusion vestibular LTP is inhibited by group II and III mGluRs during the early induction phase while it is facilitated by mGluR1 for achieving its full expression and consolidation. An additional inhibitory control is exerted by mGluR5 at the level of this facilitatory phase.
在大鼠脑干切片的内侧前庭核(MVN)中,研究了II组和III组代谢型谷氨酸受体(mGluRs)以及I组mGluRs的亚型:mGluR1、mGluR5在基础突触传递以及长时程增强(LTP)的诱导和维持中的作用。我们使用了mGluRs的选择性拮抗剂和激动剂,并分析了前庭传入刺激在高频刺激(HFS)诱导LTP前后诱发的场电位。II组和III组mGluR拮抗剂(R,S)-α-2-甲基-4-磺基苯基甘氨酸(MSPG)本身可诱导LTP,并导致配对脉冲易化(PPF)比率降低,表明谷氨酸释放增强。这表明II组和III组mGluRs在基础条件下被激活以限制谷氨酸释放。II组和III组mGluR选择性拮抗剂2S-2-氨基-2-(1S,2S-2-羧基环丙-1-基)-3-(呫吨-9-基)丙酸酯(LY341495)和(R,S)-α-甲基丝氨酸-O-磷酸酯(MSOP)均可诱导LTP,而选择性激动剂(2R,4R)-4-氨基吡咯烷-2,4-二羧酸(APDC)和L(+)-2-氨基-4-膦酰基丁酸(L-AP4)可抑制场电位并阻止HFS-LTP,其中II组mGluRs的作用比III组mGluRs更显著。mGluR1拮抗剂7-(羟基亚氨基)环丙烷[b]色烯-1a-羧酸乙酯(CPCCOEt)可阻止HFS-LTP的充分发展和维持。相比之下,mGluR5拮抗剂2-甲基-6-苯基乙炔基吡啶(MPEP)本身可诱导LTP,该作用可被CPCCOEt阻断,并且它对HFS诱导的LTP一旦形成后没有影响。PPF分析显示在MPEP增强过程中谷氨酸释放增强。I组mGluR激动剂(R,S)-3,5-二羟基苯基甘氨酸(DHPG)本身可诱导LTP,该作用可被CPCCOEt阻断。相比之下,mGluR5激动剂(R,S)-2-氯-5-羟基苯基甘氨酸(CHPG)可阻止HFS和DHPG诱发的LTP。总之,在前庭LTP的早期诱导阶段,II组和III组mGluRs起抑制作用,而mGluR1则促进其充分表达和巩固。在这个促进阶段,mGluR5还发挥额外的抑制性控制作用。